CAS: 133730-34-4; 2,4-Dimethoxyphenylboronic Acid

相似化合物

214360-69-7 135159-25-0 23112-96-1

上下游产品

CAS号17715-69-4 1-溴-2,4-二甲氧基苯 | CAS号5419-55-6 硼酸三异丙酯 | CAS号151-10-0 间苯二甲醚 | CAS号688-74-4 硼酸三丁酯 | CAS号138109-49-6 2,4-二甲氧基苯基溴化镁 溶液 | CAS号1119454-89-5 4-(2,4-dimethox... | CAS号3153-72-8 2,2',4,4'-四甲氧基-... | CAS号32565-33-6 1-benzyl-2,4-di... | CAS号178055-99-7 1-(2`,4`-Dimeth... | CAS号2284-30-2 4-苯甲基间苯二酚 | CAS号116107-12-1 methyl 2-(2,4-d... | CAS号733776-45-9 6-(2,4-二甲氧基苯基)烟酸 | CAS号7578-51-0 2-(2,4-dimethox... | CAS号98061-24-6 2-(2,4-dimethox... | CAS号63487-16-1 2,4-二甲氧基黄酮

(2,4-Dimethoxyphenyl)-Trifluoroboranuide 以 Phosphate Buffer 用作溶剂,化学反应生成2,4-二甲氧基苯硼酸
参考文献:Substituent Effects On Aryltrifluoroborate Solvolysis In Water: Implications For Suzuki−miyaura Coupling And The Design Of Stable 18F-Labeled Aryltrifluoroborates For Use In Pet Imaging
标题:Substituent Effects On Aryltrifluoroborate Solvolysis In Water: Implications For Suzuki−miyaura Coupling And The Design Of Stable 18F-Labeled Aryltrifluoroborates For Use In Pet Imaging
摘要:Whereas Electron Withdrawing Substituents Retard The Rate Of Aryltrifluoroborate Solvolysis,Electron-Donating Groups Enhance It. Herein Is Presented A Hammett Analysis Of The Solvolytic Lability Of Aryltrifluoroborates Where Log(K(Solv)) Values Correlate To Sigma Values With A Rho Value Of Approximately-1. This Work Provides A Predictable Rubric For Tuning The Reactivity Of Boron For Several Uses Including F-18-Labeled Pet Reagents And Has Mechanistic Implications For Arbf3-Enhanced Ligandless Metal-Mediated Cross Coupling Reactions With Aryltrifluoroborates.
Doi:10.1021/jo800681D

专利信息

专利号:WO-2024015528-A1
优先权日:2022-07-15
标题 :Efficient procedure for the synthesis of hydrazone-linked tetrahedral nanocages
发明人：SCHNEEBELI SEVERIN; VESTRHEIM OLAV
权利人:UNIV VERMONT
摘要:The present application is directed to a nanocage of Formula (I): wherein A and R are as described herein. The present application is also directed to an efficient process for preparation of a nanocage of Formula (I), which allows for efficient scale-up of the nanocage synthesis. Furthermore, this new process allows for rapid nanocage diversification, due a newly introduced late-stage functionalization method.

专利号:US-7176312-B2
优先权日:2001-10-12
标 题:Kinase inhibitor scaffolds and methods for their preparation
发明人：DING SHENG; DING QIANG; GRAY NATHANAEL S
权利人:IRM LLC
摘要:General methods for the solution phase as well as solid phase synthesis of various substituted heteroaryls has been demonstrated. These substituted heteroaryls can be further elaborated by aromatic substitution with amines at elevated temperature or by anilines, boronic acids and phenols via palladium catalyzed cross-coupling reactions.

专利号:US-9988371-B2
优先权日:2014-06-03
标 题:Benzimidazole analogues and related methods
发明人：LI HONG-YU; FRETT BRENDAN; SANTORO MASSIMO; CARLOMAGNO FRANCESCA
权利人:UNIV ARIZONA; UNIV FEDERICO II; UNIV ARIZONA
摘要:The invention relates to compounds of the formula (VIII) wherein the moieties R 1 , R 2 , R 3 , R 4 , and R 5 are as defined in the specification, and salts thereof, as well as their use, methods of use for them, methods of their synthesis, and the like. The compounds are protein tyrosine kinase inhibitors and can be used in the treatment of various cancer diseases and cancer-associated pain.

专利号:US-9951062-B2
优先权日:2012-12-14
标 题 :Substituted 1 H-pyrrolo [2, 3-b] pyridine and 1 H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
发明人：VANKAYALAPATI HARIPRASAD; YERRAMREDDY VENKATAKRISHNAREDDY; GANIPISETTY VENU BABU; TALLURI SURESHKUMAR; APPALANENI RAJENDRA P
权利人:ARRIEN PHARMACEUTICALS LLC
摘要:Compounds according to Formulas I, IA or IB: n nto pharmaceutically acceptable composition, salts thereof, their synthesis and their use as SIK2 inhibitors including such compounds and methods of using said compounds in the treatment of various diseases and/or disorders such as cancer, stroke, cardiovascular, obesity and type II diabetes.

专利号:US-8133840-B2
优先权日:2004-06-07
标 题:Stable composite material comprising supported porous gels
发明人：MIKA ALICJA M; WANG MAGGIE SANJU; CHILDS RONALD F
权利人:MIKA ALICJA M; WANG MAGGIE SANJU; CHILDS RONALD F; NATRIX SEPARATIONS INC
摘要:This invention relates to a stable composite material comprising a support member that has a plurality of pores extending through the support member, and a macroporous crosslinked gel that is located in, and fills, the pores of the support member, in which crosslinked gel is entrapped a stabilizing polymer, which stabilizing polymer is neutral, linear or branched, non-crosslinked, and substantially water-insoluble. The presence of the stabilizing polymer is such that it allows the composite material to largely retain its porosity and morphology after being dried. The invention also relates to a process for preparing the stable composite material described above, and to its use. The stable composite material is suitable, for example, for separation of substances, for example by filtration or adsorption, including chromatography, for use as a support in synthesis or for use as a support for cell growth.

专利号:US-6599921-B2
优先权日:2001-02-22
标 题:Non-steroidal estrogen receptor ligands
发明人：SCHMIDT JONATHAN MARTIN; MERCURE JULIE; LOWELL JEFFRY LAWRENCE; KWIATKOWSKI STEFAN; PUPEK KRZYSZTOF; ZHU SHUGUANG; WHELAN JOHN; LAZAROWYCH NATALIE
权利人:NANODESIGN INC
摘要:Novel non-steroidal estrogen receptor ligands and methods of synthesis are disclosed. The novel molecules are intended for use in therapeutic preparations for the treatment of estrogen receptor related disease states. The compounds specified are tetra-cyclic derivatives and have been shown to be antiproliferative against human estrogen-dependent cancer cells and to have good binding affinity for the estrogen receptor.